Search fresh public links, source activity, and ready-to-use post angles for Bionyra Pharma.
Fresh curated links around Bionyra Pharma are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The biotech, co-founded by Sofinnova Partners and a former Sanofi immunology R&D head, is testing new biologics against common immune conditions.
Bionyra is emerging from stealth with an oversubscribed Series A round of $165 million co-led by Jeito Capital and Sofinnova Partners. Arkin Bio, Sanofi Ventures, Sixty Degree Capi...
Bionyra Pharma’s pipeline includes two drugs that target the signaling protein TL1A, alone and as part of a combination approach to treat inflammatory disorders. The startup’s laun...
The company, which emerged from stealth this week, is using the funds to develop and test three therapeutic assets that it licensed from external partners as well as to progress so...
Innoviva has revealed the next steps for Langer Lab assets it rescued from Lyndra Therapeutics’ collapse, launching Nortiva Bio to develop long-acting oral medicines and pursue dru...
Transaction Valued at $122.5M Establishes 20,000-Liter US Biologics Drug Substance Manufacturing Platform, Covering Development through Commercial Supply TAIPEI, TAIWAN – Media Out...
Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global pharmaceutical manufac...
BioMarin Pharmaceutical Anonymous (not verified) Mon, 06/22/2026 - 00:00 field_thread_url https://cafepharma.com/boards/threads/biomarin-pharmaceutical.710...
BioMarin Pharmaceutical Anonymous (not verified) Fri, 06/12/2026 - 17:51 field_thread_url https://cafepharma.com/boards/threads/biomarin-pharmaceutical.710...
BridgeBio Anonymous (not verified) Thu, 07/09/2026 - 09:10 field_thread_url https://cafepharma.com/boards/threads/bridgebio.698762/ boar...
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma.
Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug innovation model
The startup is developing a medicine that works differently than available treatments for thyroid eye disease and could benefit people with a related condition, too.
This biotechnology firm leverages machine learning to design novel protein therapeutics targeting unmet medical needs.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.